Essentiality and Toxicity in Copper Health Risk Assessment: Overview, Update and Regulatory Considerations

被引:322
作者
Stern, Bonnie Ransom [1 ]
机构
[1] BR Stern & Associates LLC, Consulting Hlth Sci & Risk Assessment, Annandale, VA 22003 USA
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES | 2010年 / 73卷 / 2-3期
关键词
EXCESS DIETARY COPPER; STABLE-ISOTOPE CU-65; ADVERSE-EFFECT LEVEL; DRINKING-WATER; LOADED RAT; CELLULAR MECHANISMS; ULTRASTRUCTURAL-CHANGES; FISCHER-344; RATS; FOODCUE PROJECT; PROTECTIVE ROLE;
D O I
10.1080/15287390903337100
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Copper (Cu), an essential element required as a cofactor and/or structural component of numerous metalloenzymes, is uniquely positioned as a case study for issues associated with the essential metals health risk assessment, because of its extensive database. Essential elements pose distinct challenges when establishing regulatory guidelines because too little as well as too much intake can produce adverse health consequences and the dose-response curve is roughly U-shaped. Thus, conventional health risk assessment paradigms do not apply to essential elements; the dose-response assessment needs to define an acceptable range of oral intake (AROI) which prevents deficiency by meeting nutritional requirements while avoiding toxicity due to high intakes. The conceptual framework for this type of risk assessment includes consideration of biological processes that are unique to essential elementshomeostasis, basal and normative nutritional requirements, bioavailability, and nutrient-nutrient interactions. In this paper, the Cu database on physiology, deficiency, and excess is briefly reviewed in order to establish the range of potential health hazards associated with varying levels of intake. Issues discussed include the (1) development of suitable dose-response methodologies, including appropriate dose and response metrics, for Cu; (2) categorization of severity of response and functional significance; (3) use of endpoints of similar severity and functionality for deficiency and excess in dose-response assessment; (4) development of valid biomarkers for subclinical effects, exposures and susceptibilities. Guideline values for Cu intake have been established by nutritional and toxicologic regulatory or advisory boards. Although regulators are more concerned with the potential human toxicity arising from excessive Cu intake, the preponderance of evidence suggests that deficiency is more of a public health concern than excess.
引用
收藏
页码:114 / 127
页数:14
相关论文
共 93 条
[41]  
Institute of Medicine Food and Nutrition Board, 2001, Dietary Reference Intakes for Vitamin A, Vitamin K, Boron, Chromium, Copper, Iodine, Iron, Manganese. Molybdenum, Nickel, Silicon, Vanadium and Zinc, DOI DOI 10.17226/10026
[42]  
International Agency for the Research on Cancer (IARC), 2008, IARC MON EV CARC RIS
[43]   Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency [J].
Kaler, SG .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 67 (05) :1029S-1034S
[44]   Effect of copper deficiency on prenatal development and pregnancy outcome [J].
Keen, CL ;
Uriu-Hare, JY ;
Hawk, SN ;
Jankowski, MA ;
Daston, GP ;
Kwik-Uribe, CL ;
Rucker, RB .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 67 (05) :1003S-1011S
[45]  
KNOBELOCH L, 1994, ENVIRON HEALTH PERSP, V102, P958
[46]   Myelodysplasia, myeloneuropathy, and copper deficiency [J].
Kumar, N ;
Elliott, MA ;
Hoyer, JD ;
Harper, CM ;
Ahlskog, JE ;
Phyliky, RL .
MAYO CLINIC PROCEEDINGS, 2005, 80 (07) :943-946
[47]   Possible mechanisms underlying copper-induced damage in biological membranes leading to cellular toxicity [J].
Letelier, ME ;
Lepe, AM ;
Faúndez, M ;
Salazar, J ;
Marín, R ;
Aracena, P ;
Speisky, H .
CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 151 (02) :71-82
[48]   Marginal dietary copper restriction induces cardiomyopathy in rats [J].
Li, Y ;
Wang, LP ;
Schuschke, DA ;
Zhou, ZX ;
Saari, JT ;
Kang, YJ .
JOURNAL OF NUTRITION, 2005, 135 (09) :2130-2136
[49]   The molecular basis of copper homeostasis and copper-related disorders [J].
Llanos, RM ;
Mercer, JFB .
DNA AND CELL BIOLOGY, 2002, 21 (04) :259-270
[50]   Wilson's disease [J].
Loudianos, G ;
Gitlin, JD .
SEMINARS IN LIVER DISEASE, 2000, 20 (03) :353-364